Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,355
Closed -$208K 872
2022
Q1
$208K Sell
4,355
-388
-8% -$19.2K 0.01% 785
2021
Q4
$241K Buy
+4,743
New +$211K 0.01% 781
2018
Q4
Sell
-2,647
Closed -$218K 733
2018
Q3
$218K Buy
+2,647
New +$210K 0.01% 811
2015
Q4
Sell
-7,494
Closed -$309K 895
2015
Q3
$309K Buy
7,494
+107
+1% +$4.59K 0.03% 614
2015
Q2
$355K Buy
7,387
+387
+6% +$20.9K 0.02% 685
2015
Q1
$420K Sell
7,000
-305
-4% -$15.5K 0.01% 1043
2014
Q4
$319K Sell
7,305
-475
-6% -$21K 0.02% 694
2014
Q3
$350K Sell
7,780
-7,183
-48% -$382K 0.02% 732
2014
Q2
$1.11M Buy
14,963
+2,278
+18% +$180K 0.07% 311
2014
Q1
$1.05M Buy
12,685
+7,755
+157% +$681K 0.09% 232
2013
Q4
$681K Sell
4,930
-483
-9% -$56.9K 0.07% 287
2013
Q3
$518K Buy
+5,413
New +$459K 0.06% 289

Other funds holding NUS

FDx Advisors's NUS Position: Q2 2022 in Review

FDx Advisors sold out of Nu Skin (NUS) in Q2 2022, closing a stake of 4,355 shares — an estimated $208K sold.

FDx Advisors first reported a position in NUS in Q3 2013 and held it in 12 quarters. The position peaked at $1.11M in Q2 2014. 222 funds tracked by Wall St. Rank hold NUS as of Q2 2022.

  • FDx Advisors reported no remaining Nu Skin position as of Q2 2022 after selling out during the quarter.
  • FDx Advisors sold 4,355 Nu Skin shares in Q2 2022, an estimated $208K.
  • FDx Advisors first reported a position in Nu Skin in Q3 2013 and held it in 12 quarters.
  • FDx Advisors's Nu Skin position peaked at $1.11M in Q2 2014.
  • 222 funds tracked by Wall St. Rank held Nu Skin as of Q2 2022.

Based on FDx Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.